Clinical Trial Update: RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) [Phase 4]

View source ↗

Summary

Phase 4 randomized trial of a brain longitudinal biomarker study (OPT-Neuro) related to depression and dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia
• Major Depressive Disorder

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Depression, Dementia | Phase 4 | Status: COMPLETED